Page 78 - ITPS-7-2

INNOSC Theranostics and
Pharmacological Sciences Youth brain health check and dysregulation

135. Rotem A, Danieli Y, Ben-Sheetrit J, et al. Apparent lack of potential: An accurate predictor of memory impairment.
practice effects in the test of variables of attention (TOVA) in Clin Electroencephalogr. 2003;34(3):124-139.
adult ADHD. Atten Defic Hyperact Disord. 2019;11(1):73-81.
doi: 10.1177/155005940303400306
doi: 10.1007/s12402-018-0278-5
146. Braverman ER, Chen TJ, Chen AL, et al. Preliminary
136. Wojcik CM, Beier M, Costello K, et al. Computerized investigation of plasma levels of sex hormones and human
neuropsychological assessment devices in multiple sclerosis: growth factor(s), and P300 latency as correlates to cognitive
A systematic review. Mult Scler. 2019;25(14):1848-1869. decline as a function of gender. BMC Res Notes. 2009;2:126.
doi: 10.1177/1352458519879094 doi: 10.1186/1756-0500-2-126
137. Lubar JF, Swartwood MO, Swartwood JN, O’Donnell PH. 147. Wang GY, Kydd R, Russell BR. Resting EEG and ERPs
Evaluation of the effectiveness of EEG neurofeedback findings in methadone-substituted opiate users: A review.
training for ADHD in a clinical setting as measured by Acta Neurol Belg. 2015;115(4):539-546.
changes in T.O.V.A. scores, behavioral ratings, and WISC-R
performance. Biofeedback Self Regul. 1995;20(1):83-99. doi: 10.1007/s13760-015-0476-2
doi: 10.1007/BF01712768 148. Porcaro C, Balsters JH, Mantini D, Robertson IH,
Wenderoth N. P3b amplitude as a signature of cognitive
138. Ball SA, Nich C, Rounsaville BJ, Eagan D, Carroll KM. decline in the older population: An EEG study enhanced by
Millon clinical multiaxial inventory-III subtypes of opioid Functional Source Separation. Neuroimage. 2019;184:535-546.
dependence: Validity and matching to behavioral therapies.
J Consult Clin Psychol. 2004;72(4):698-711. doi: 10.1016/j.neuroimage.2018.09.057
doi: 10.1037/0022-006X.72.4.698 149. Campanella S, Pogarell O, Boutros N. Event-related
potentials in substance use disorders: A narrative review
139. Strack S, Millon T. Contributions to the dimensional based on articles from 1984 to 2012. Clin EEG Neurosci.
assessment of personality disorders using Millon’s model 2014;45(2):67-76.
and the Millon Clinical Multiaxial Inventory (MCMI9-III).
J Pers Assess. 2007;89(1):56-69. doi: 10.1177/1550059413495533
nd
doi: 10.1080/00223890701357217 150. Kalechstein AD, De la Garza R 2 , Newton TF, Green MF,
Cook IA, Leuchter AF. Quantitative EEG abnormalities
140. Choca JP, Grossman SD. Evolution of the millon clinical are associated with memory impairment in recently
multiaxial inventory. J Pers Assess. 2015;97(6):541-549.
abstinent methamphetamine-dependent individuals.
doi: 10.1080/00223891.2015.1055753 J Neuropsychiatry Clin Neurosci. 2009;21(3):254-258.
141. Blum K, Chen TJ, Morse S, et al. Overcoming qEEG doi: 10.1176/jnp.2009.21.3.254
abnormalities and reward gene deficits during protracted
abstinence in male psychostimulant and polydrug abusers 151. Bjørk MH, Sand T, Bråthen G, et al. Quantitative EEG
utilizing putative dopamine D₂ agonist therapy: Part 2. findings in patients with acute, brief depression combined
Postgrad Med. 2010;122(6):214-226. with other fluctuating psychiatric symptoms: A controlled
study from an acute psychiatric department. BMC
doi: 10.3810/pgm.2010.11.2237 Psychiatry. 2008;8:89.
142. Sokhadze TM, Cannon RL, Trudeau DL. EEG biofeedback doi: 10.1186/1471-244X-8-89
as a treatment for substance use disorders: Review, rating
of efficacy, and recommendations for further research. Appl 152. McVoy M, Lytle S, Fulchiero E, Aebi ME, Adeleye O,
Psychophysiol Biofeedback. 2008;33(1):1-28. Sajatovic M. A systematic review of quantitative EEG
as a possible biomarker in child psychiatric disorders.
doi: 10.1007/s10484-007-9047-5 Psychiatry Res. 2019;279:331-344.
143. van Dinteren R, Arns M, Jongsma ML, Kessels RP. P300 doi: 10.1016/j.psychres.2019.07.004
development across the lifespan: A systematic review and
meta-analysis. PLoS One. 2014;9(2):e87347. 153. Haghighi M, Ludyga S, Rahimi B, et al. In patients suffering
from major depressive disorders, quantitative EEG showed
doi: 10.1371/journal.pone.0087347 favorable changes in left and right prefrontal cortex.
144. Braverman ER, Han D, Oscar-Berman M, et al. Menopause Psychiatry Res. 2017;251:137-141.
analytical hormonal correlate outcome study (MAHCOS) doi: 10.1016/j.psychres.2017.02.012
and the association to brain electrophysiology (P300) in a
clinical setting. PLoS One. 2014;9(9):e105048. 154. Gerez M, Tello A. Clinical significance of focal topographic
changes in the electroencephalogram (EEG) and evoked
doi: 10.1371/journal.pone.0105048 potentials (EP) of psychiatric patients. Brain Topogr.
145. Braverman ER, Blum K. P300 (latency) event-related 1992;5(1):3-10.

Volume 7 Issue 2 (2024) 18 doi: 10.36922/itps.1472